eplerenone and Pulmonary-Fibrosis

Progression of chronic kidney disease (CKD) to uremia is often accompanied by varying degrees of lung damage and this is also an important cause of death. Although there are many studies on the mechanism of lung injury, it is not clearly understood. Inflammatory macrophages may associated with fibrosis in the lungs. Here, we investigated the role of macrophage-myofibroblast transition (MMT) in lung fibrosis with unilateral ureteral obstruction (UUO) rats. We found that cells undergoing MMT accounted for an important part of the myofibroblast population, and correlated with lung fibrosis, MMT cells in lungs have a predominant M2 phenotype, and this process was attenuated after treatment with eplerenone. In conclusion, our studies provide a possible mechanism for UUO-induced kidney damage and lung injury, indicating the possibility of using eplerenone, a mineralocorticoid receptor blocker, to treat UUO to reduce kidney damage and protect lung function.

Topics: Animals; Cell Differentiation; Disease Models, Animal; Eplerenone; Humans; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Myofibroblasts; Protective Agents; Pulmonary Fibrosis; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Ureteral Obstruction